FINANCIALS

SUPN Supernus Pharmaceuticals Inc 1356576

Income Statement
Revenue	supn-20241231	661,817,000
Net Income	supn-20241231	73,865,000
Profit Margin		11.16%

Balance Sheet
Current Assets	686,070,000
Assets	1,368,073,000
Current Liabilities	292,397,000
Liabilities	332,340,000
Equity	1,035,733,000
Shares Out	55,105,000

Cash Flow Statement
Operating Cash Flow	171,951,000
Investing Cash Flow	-189,867,000

Market Analysis
Market Cap	1,746,841,222
Price	32.26
BVPS	18.80
PB	1.70
EPS	0.09
PE	359.05
PS	0.66
FCF	-17,916,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view SUPN documents filed with the SEC.

SUPN Filings Clear

View A List of Tickers